Global Patient Registry Software Market: Information by Type of Registry (Disease Registries, Health Service Registries, Product Registries and others), Functionality (Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE) and others), Deployment Model (On-Premise and Cloud), End-User (Hospitals and Clinics, Government Organizations & Research Centers and Others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025
ID: MRFR/HCIT/5452-CR | October 2019 | Region: Global | 106 pages
Market Overview
The Patient Registry Software Market is expected to register a CAGR of 11.08% to reach USD 1,998.83 Million by 2025.
Patient registry software is an organized system that utilizes observational study methods for collecting clinical as well as non-clinical patient data for evaluation of specified outcomes for a population that is defined by a particular disease, condition, or exposure, and that serves a predetermined clinical, scientific, or policy purposes. The demand for patient registry software s is increasing due to the high adoption rate of electronic health records and increasing use of patient registry data for post-marketing surveillance. These factors are expected to fuel the growth of the global patient registry software market. However, privacy and data security-related concerns are anticipated to hamper the market growth.
Market Dynamics
EHRs are a step toward the progress of the healthcare system that can strengthen the relationship between patients and clinicians. The data and the timeliness and availability of it will enable providers to make better decisions and provide better care. All these advantages encourage clinicians and hospitals to keep accurate records of all their patients hence leading to the high adoption of electronic health records (EHRs) increasing globally. For instance, according to the American Hospital Association Annual Survey Information Technology Supplement, 96% of hospitals in the US adopted certified EHRs in 2017.
Similarly, according to research estimates of the National Center for Biotechnology Information (NCBI) published in August 2017, the annual rate of EHR adoption for eligible hospitals raised from 3.2% to 14.2% after the Health Information Technology for Economic and Clinical Health (HITECH) Act. Ineligible hospitals, with a low rate of adoption of EHR, also increased from 0.1% to 3.3%. Consequently, increasing adoption has led to the growth of the global patient registry software market. Hence the increasing adoption of EHRs is fueling the growth of the worldwide patient registry software market.
Global Patient Registry Software Market Share, by End User, 2018 (%) 
Source: MRFR Analysis
Segmentation
The global patient registry software market has been segmented on the basis of the type of registry into disease registries, health service registries, product registries, and others. Based on functionality, it is further divided into population health management (PHM), patient care management, health information exchange (HIE), and others. On the basis of deployment model, it is bifurcated into on-premise and cloud. Based on the end-user it is further segmented into hospitals and clinics, government organizations & research centers, and others.
Western Europe Patient Registry Software Market Share, 2018 (%) 
Source: MRFR Analysis
Regional Analysis
The Global Patient Registry Software Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global patient registry software market. The growth in this region can be attributed to the development of digital infrastructure in healthcare and well-established EHRs. Moreover, many key companies in the market are acquiring regional vendors to strengthen their position in the market. For instance, according to The Office of the National Coordinator for Health Information Technology, in the US, as of 2017, nearly 9 out of 10 (86%) office-based physicians had non-certified EHR systems, and approximately 4 out of 5 (80%) adopted a certified her systems. Since 2008, adoption of any EHRs by office-based physicians has increased significantly from 42% to 86%. Europe held a substantial share in the global patient registry software market. This can be attributed to increasing government initiatives for the implementation of patient registries. Asia-Pacific is estimated to be the fastest-growing region in the global market. This is due to the various initiatives taken by the government for the reduction of the rising pressure to improve the quality of care and reduction of healthcare costs fueling the growth of the patient registry software market in the region. The patient registry software market in the Middle East & Africa is expected to witness steady growth during the review period due to limited access and healthcare affordability among the population. Increasing awareness about patient registry software is expected to drive market growth during the assessment period.
Key Players
The Prominent Players in the global patient registry software market are ArborMetrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc., phamax, IBM, and IQVIA.
Some of the key strategies followed by players operating in the global patient registry software market were innovation, product development, and acquisition & mergers.
- In July 2019, ArborMetrix signed a partnership agreement with the American Academy of Sleep Medicine for creating the first clinical registry dedicated solely to sleep medicine.
- In August 2019, Evado launched the eConsent App for healthcare organizations to record patient consent for clinical trials, disease-related studies, or registries.
- In November 2019, Optum, Inc. acquired the Polyclinic, a multi-specialty clinic providing primary care through specialty physicians in the US. This acquisition has helped Optum to expand its business in the healthcare sector.
Market Segmentation
Global Patient Registry Software Market, by Type of Registry
- Disease Registries
- Health Service Registries
- Product Registries
- Others
Global Patient Registry Software Market, by Functionality
- Population Health Management (PHM)
- Patient Care Management
- Health Information Exchange (HIE)
- Others
Global Patient Registry Software Market, by Deployment Model
- On-Premise
- Cloud
Global Patient Registry Software Market, by End User
- Hospitals and Clinics
- Government Organizations & Research Centers
- Others
Global Patient Registry Software Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Available Additional Customizations
Company Profiles
- Global Vision Technologies, Inc.
- Phytel, Inc.
- Liaison Technologies
- ImageTrend, Inc.
- Velos LLC.
Intended Audience
- Pharmaceutical companies
- Contract research manufacturing organizations
- Research & development organizations
- Academic institutes
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 11.08% (2016-2025) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type of Registry End-User and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | ArborMetrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc., phamax, IBM, and IQVIA |
| Key Market Opportunities | Privacy and data security-related concerns are anticipated to hamper the market growth |
| Key Market Drivers | EHRs are a step toward the progress of the healthcare system that can strengthen the relationship between patients and clinicians. |
Frequently Asked Questions (FAQ) :
Patient Registry Software Market is predicted to touch USD 1,998.83 million by 2025.
Patient Registry Software Market is projected to grow at an 11.08% CAGR between 2016-2025.
Americas is projected to have a major share in the Patient Registry Software Market.
Key competitors in the Patient Registry Software Market include IQVIA, IBM, Phamax, Optum, Inc., McKesson Corporation, LUMEDX, Open Text Corporation, IFA SYSTEMS, Evado Pty. Ltd, Dacima Software Inc, and ArborMetrix.
Strategies incorporated by industry players to create a niche in the Patient Registry Software Market include extensive R&D, partnership, and acquisition.
1 Executive Summary
1.1 OVERVIEW 16
1.1.1 MARKET SYPNOSIS 16
2 Market Introduction
2.1 SCOPE OF THE STUDY 17
2.2 RESEARCH OBJECTIVE 17
2.3 LIST OF ASSUMPTIONS 17
3 Research Methodology
3.1 OVERVIEW 19
3.2 DATA MINING 19
3.3 SECONDARY RESEARCH 20
3.4 PRIMARY RESEARCH 21
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 22
3.5 FORECASTING TECHNIQUES 22
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23
3.6.1 BOTTOM-UP APPROACH 24
3.6.2 TOP-DOWN APPROACH 25
3.7 DATA TRIANGULATION 26
3.8 VALIDATION 26
4 MARKET DYNAMICS
4.1 OVERVIEW 27
4.2 DRIVERS 28
4.2.1 HIGH ADOPTION RATE OF ELECTRONIC HEALTH RECORDS (EHRS) 28
4.2.2 INCREASED GOVERNMENT INITIATIVES FOR THE IMPLEMENTATION OF PATIENT REGISTRIES 28
4.2.3 GROWING USE OF PATIENT REGISTRY DATA FOR POST-MARKETING SURVEILLANCE 29
4.2.4 RISING PRESSURE TO IMPROVE THE QUALITY OF CARE AND REDUCE HEALTHCARE COSTS 29
4.3 RESTRAINTS 31
4.3.1 PRIVACY- AND DATA SECURITY-RELATED CONCERNS 31
4.3.2 LACK OF TRAINED AND SKILLED RESOURCES 31
4.4 OPPORTUNITIES 32
4.4.1 INCREASING NUMBER OF ACCOUNTABLE CARE ORGANIZATIONS 32
4.4.2 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS (PPRNS) 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 34
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 INPUTS 37
5.2.2 SOFTWARE DEVELOPMENT PROCESS 37
5.2.3 OUTPUT 37
5.2.4 MARKETING AND DISTRIBUTION 37
5.2.5 POST-SELLING SERVICES 37
6 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY
6.1 OVERVIEW 38
6.2 DISEASE REGISTRIES 40
6.3 HEALTH SERVICE REGISTRIES 40
6.4 PRODUCT REGISTRIES 41
6.5 OTHERS 42
7 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY
7.1 OVERVIEW 43
7.2 POPULATION HEALTH MANAGEMENT (PHM) 44
7.3 PATIENT CARE MANAGEMENT 45
7.4 HEALTH INFORMATION EXCHANGE (HIE) 46
7.5 OTHERS 46
8 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL
8.1 OVERVIEW 47
8.2 ON-PREMISE 48
8.3 CLOUD 49
9 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER
9.1 OVERVIEW 50
9.2 HOSPITALS & CLINICS 51
9.3 GOVERNMENT ORGANIZATIONS & RESEARCH CENTERS 52
9.4 OTHERS 52
10 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGION
10.1 OVERVIEW 53
10.2 AMERICAS 55
10.2.1 NORTH AMERICA 58
10.2.1.1 US 60
10.2.1.2 CANADA 62
10.2.2 LATIN AMERICA 63
10.3 EUROPE 66
10.3.1 WESTERN EUROPE 68
10.3.1.1 GERMANY 71
10.3.1.2 UK 72
10.3.1.3 FRANCE 74
10.3.1.4 ITALY 76
10.3.1.5 SPAIN 77
10.3.1.6 REST OF WESTERN EUROPE 79
10.3.2 EASTERN EUROPE 81
10.4 ASIA-PACIFIC 83
10.4.1 CHINA 86
10.4.2 JAPAN 87
10.4.3 INDIA 89
10.4.4 SOUTH KOREA 91
10.4.5 AUSTRALIA 92
10.4.6 REST OF ASIA-PACIFIC 94
10.5 MIDDLE EAST & AFRICA 96
10.5.1 MIDDLE EAST 98
10.5.2 AFRICA 100
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 102
11.2 COMPANY RANKING ANALYSIS 102
11.3 COMPETITIVE BENCHMARKING 103
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 104
11.5 KEY DEVELOPMENT ANALYSIS 104
11.5.1 ACQUISITION 105
11.5.2 EXPANSION 106
11.5.3 PARTNERSHIP/MERGER 106
11.5.4 PRODUCT/SERVICE LAUNCH 107
12 COMPANY PROFILES
12.1 ARBORMETRIX 108
12.1.1 COMPANY OVERVIEW 108
12.1.2 FINANCIAL OVERVIEW 109
12.1.3 PRODUCTS/SERVICES OFFERED 109
12.1.4 KEY DEVELOPMENTS 110
12.1.5 SWOT ANALYSIS 111
12.1.6 KEY STRATEGIES 111
12.2 DACIMA SOFTWARE INC. 112
12.2.1 COMPANY OVERVIEW 112
12.2.2 FINANCIAL OVERVIEW 112
12.2.3 PRODUCTS/SERVICES OFFERED 113
12.2.4 KEY DEVELOPMENTS 113
12.2.5 SWOT ANALYSIS 114
12.2.6 KEY STRATEGIES 114
12.3 EVADO PTY. LTD 115
12.3.1 COMPANY OVERVIEW 115
12.3.2 FINANCIAL OVERVIEW 115
12.3.3 PRODUCTS/SERVICES OFFERED 116
12.3.4 KEY DEVELOPMENTS 116
12.3.5 SWOT ANALYSIS 117
12.3.6 KEY STRATEGIES 117
12.4 IFA SYSTEMS 118
12.4.1 COMPANY OVERVIEW 118
12.4.2 FINANCIAL OVERVIEW 119
12.4.3 PRODUCTS/SERVICES OFFERED 119
12.4.4 KEY DEVELOPMENTS 119
12.4.5 SWOT ANALYSIS 120
12.4.6 KEY STRATEGIES 120
12.5 OPEN TEXT CORPORATION 121
12.5.1 COMPANY OVERVIEW 121
12.5.2 FINANCIAL OVERVIEW 122
12.5.3 PRODUCTS/SERVICES OFFERED 123
12.5.4 KEY DEVELOPMENTS 123
12.5.5 SWOT ANALYSIS 124
12.5.6 KEY STRATEGIES 124
12.6 LUMEDX 125
12.6.1 COMPANY OVERVIEW 125
12.6.2 FINANCIAL OVERVIEW 125
12.6.3 PRODUCTS/SERVICES OFFERED 126
12.6.4 KEY DEVELOPMENTS 126
12.6.5 SWOT ANALYSIS 126
12.6.6 KEY STRATEGIES 127
12.7 MCKESSON CORPORATION 128
12.7.1 COMPANY OVERVIEW 128
12.7.2 FINANCIAL OVERVIEW 129
12.7.3 PRODUCTS/SERVICES OFFERED 129
12.7.4 KEY DEVELOPMENTS 129
12.7.5 SWOT ANALYSIS 130
12.7.6 KEY STRATEGIES 130
12.8 OPTUM, INC. 131
12.8.1 COMPANY OVERVIEW 131
12.8.2 FINANCIAL OVERVIEW 131
12.8.3 PRODUCTS/SERVICES OFFERED 132
12.8.4 KEY DEVELOPMENTS 132
12.8.5 SWOT ANALYSIS 133
12.8.6 KEY STRATEGIES 133
12.9 PHAMAX AG 134
12.9.1 COMPANY OVERVIEW 134
12.9.2 FINANCIAL OVERVIEW 134
12.9.3 PRODUCTS/SERVICES OFFERED 134
12.9.4 KEY DEVELOPMENTS 134
12.9.5 SWOT ANALYSIS 135
12.9.6 KEY STRATEGIES 135
12.10 IBM 136
12.10.1 COMPANY OVERVIEW 136
12.10.2 FINANCIAL OVERVIEW 136
12.10.3 PRODUCTS/SERVICES OFFERED 137
12.10.4 KEY DEVELOPMENTS 137
12.10.5 SWOT ANALYSIS 138
12.10.6 KEY STRATEGIES 138
12.11 IQVIA 139
12.11.1 COMPANY OVERVIEW 139
12.11.2 FINANCIAL OVERVIEW 140
12.11.3 PRODUCTS/SERVICES OFFERED 140
12.11.4 KEY DEVELOPMENTS 141
12.11.5 SWOT ANALYSIS 141
12.11.6 KEY STRATEGIES 142
13 APPENDIX
13.1 REFERENCES 143
13.2 RELATED REPORTS 143
14 List Of Tables
TABLE 1 LIST OF ASSUMPTIONS 17
TABLE 2 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 38
TABLE 3 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR DISEASE REGISTRIES, BY REGION, 2020–2027 (USD MILLION) 40
TABLE 4 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH SERVICE REGISTRIES, BY REGION, 2020–2027 (USD MILLION) 41
TABLE 5 GLOBAL PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2020-2027 (USD MILLION) 41
TABLE 6 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY REGION, 2020–2027 (USD MILLION) 42
TABLE 7 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 43
TABLE 8 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR POPULATION HEALTH MANAGEMENT (PHM), BY REGION, 2020–2027 (USD MILLION) 45
TABLE 9 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR PATIENT CARE MANAGEMENT, BY REGION, 2020–2027 (USD MILLION) 45
TABLE 10 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR HEALTH INFORMATION EXCHANGE (HIE), BY REGION, 2020–2027 (USD MILLION) 46
TABLE 11 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 47
TABLE 12 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR CLOUD, BY REGION, 2020–2027 (USD MILLION) 49
TABLE 13 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 50
TABLE 14 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 51
TABLE 15 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR GOVERNMENT ORGANIZATIONS & RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION) 52
TABLE 16 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 53
TABLE 17 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 18 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 56
TABLE 19 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 56
TABLE 20 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 56
TABLE 21 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 57
TABLE 22 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 57
TABLE 23 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 58
TABLE 24 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 58
TABLE 25 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 59
TABLE 26 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 59
TABLE 27 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 59
TABLE 28 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 60
TABLE 29 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 60
TABLE 30 US: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 60
TABLE 31 US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 61
TABLE 32 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 61
TABLE 33 US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 61
TABLE 34 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 62
TABLE 35 CANADA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 62
TABLE 36 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 62
TABLE 37 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 63
TABLE 38 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 63
TABLE 39 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 63
TABLE 40 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 64
TABLE 41 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 64
TABLE 42 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 64
TABLE 43 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 65
TABLE 44 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2020–2024 (USD MILLION) 66
TABLE 45 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 67
TABLE 46 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 47 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 67
TABLE 48 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 68
TABLE 49 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 68
TABLE 50 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68
TABLE 51 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 69
TABLE 52 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 53 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 70
TABLE 54 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 70
TABLE 55 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 70
TABLE 56 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 71
TABLE 57 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 58 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 71
TABLE 59 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD ILLION) 72
TABLE 60 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 72
TABLE 61 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 72
TABLE 62 UK: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 63 UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 73
TABLE 64 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 73
TABLE 65 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 74
TABLE 66 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 74
TABLE 67 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 68 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 75
TABLE 69 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 75
TABLE 70 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 75
TABLE 71 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 76
TABLE 72 ITALY: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 76
TABLE 73 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 76
TABLE 74 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 77
TABLE 75 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 77
TABLE 76 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 77
TABLE 77 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 78
TABLE 78 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 78
TABLE 79 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 78
TABLE 80 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 79
TABLE 81 REST OF WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 79
TABLE 82 REST OF WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 83 REST OF WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 80
TABLE 84 REST OF WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 80
TABLE 85 REST OF WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 80
TABLE 86 EASTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 81
TABLE 87 EASTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 88 EASTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 81
TABLE 89 EASTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 82
TABLE 90 EASTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 82
TABLE 91 ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 92 ASIA_PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 84
TABLE 93 ASIA_PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 94 ASIA_PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 85
TABLE 95 ASIA_PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 85
TABLE 96 ASIA_PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 85
TABLE 97 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 86
TABLE 98 CHINA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 99 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 86
TABLE 100 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 87
TABLE 101 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 87
TABLE 102 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 87
TABLE 103 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 104 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 88
TABLE 105 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 88
TABLE 106 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 89
TABLE 107 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 89
TABLE 108 INDIA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 109 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 90
TABLE 110 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 90
TABLE 111 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 90
TABLE 112 SOUTH KOREA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 91
TABLE 113 SOUTH KOREA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 114 SOUTH KOREA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 91
TABLE 115 SOUTH KOREA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 92
TABLE 116 SOUTH KOREA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 92
TABLE 117 AUSTRALIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 92
TABLE 118 AUSTRALIA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 119 AUSTRALIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 93
TABLE 120 AUSTRALIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 93
TABLE 121 AUSTRALIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 94
TABLE 122 REST OF ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 94
TABLE 123 REST OF ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 94
TABLE 124 REST OF ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 95
TABLE 125 REST OF ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 95
TABLE 126 REST OF ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 95
TABLE 127 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 128 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 97
TABLE 129 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 130 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 97
TABLE 131 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 98
TABLE 132 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 98
TABLE 133 MIDDLE EAST: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 98
TABLE 134 MIDDLE EAST: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 135 MIDDLE EAST: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 99
TABLE 136 MIDDLE EAST: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 99
TABLE 137 MIDDLE EAST: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 100
TABLE 138 AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020–2027 (USD MILLION) 100
TABLE 139 AFRICA: PATIENT REGISTRY SOFTWARE MARKET, FOR PRODUCT REGISTRIES, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 140 AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 101
TABLE 141 AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION) 101
TABLE 142 AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 101
TABLE 143 COMPANY RANKING ANALYSIS 102
TABLE 144 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PATIENT REGISTRY SOFTWARE MARKET 104
TABLE 145 ACQUISITION: GLOBAL PATIENT REGISTRY SOFTWARE MARKET 105
TABLE 146 EXPANSION: GLOBAL PATIENT REGISTRY SOFTWARE MARKET 106
TABLE 147 PARTNERSHIP/MERGER: GLOBAL PATIENT REGISTRY SOFTWARE MARKET 106
TABLE 148 PRODUCT/SERVICE LAUNCH: GLOBAL PATIENT REGISTRY SOFTWARE MARKET 107
TABLE 149 ARBORMETRIX: PRODUCTS/SERVICES OFFERED 109
TABLE 150 ARBORMETRIX: KEY DEVELOPMENTS 110
TABLE 151 DACIMA SOFTWARE INC.: PRODUCTS/SERVICES OFFERED 113
TABLE 152 DACIMA SOFTWARE INC.: KEY DEVELOPMENTS 113
TABLE 153 EVADO PTY. LTD.: PRODUCTS/SERVICES OFFERED 116
TABLE 154 EVADO PTY. LTD.: KEY DEVELOPMENTS 116
TABLE 155 IFA SYSTEMS: PRODUCTS/SERVICES OFFERED 119
TABLE 156 OPEN TEXT CORPORATION: PRODUCTS/SERVICES OFFERED 123
TABLE 157 OPEN TEXT CORPORATION: KEY DEVELOPMENTS 123
TABLE 158 LUMEDX.: PRODUCTS/SERVICES OFFERED 126
TABLE 159 MCKESSON CORPORATION.: PRODUCTS/SERVICES OFFERED 129
TABLE 160 OPTUM, INC.: PRODUCTS/SERVICES OFFERED 132
TABLE 161 OPTUM, INC.: KEY DEVELOPMENTS 132
TABLE 162 PHAMAX AG.: PRODUCTS/SERVICES OFFERED 134
TABLE 163 IBM: PRODUCTS/SERVICES OFFERED 137
TABLE 164 IBM: KEY DEVELOPMENTS 137
TABLE 165 IQVIA: PRODUCTS/SERVICES OFFERED 140
TABLE 166 IQVIA: KEY DEVELOPMENTS 141
15 List Of Figures
FIGURE 1 GLOBAL PATIENT REGISTRY SOFTWARE MARKET STRUCTURE 18
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 24
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF GLOBAL PATIENT REGISTRY SOFTWARE MARKET 27
FIGURE 4 DRIVER IMPACT ANALYSIS 30
FIGURE 5 RESTRAINT IMPACT ANALYSIS 32
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PATIENT REGISTRY SOFTWARE MARKET 34
FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL PATIENT REGISTRY SOFTWARE MARKET 36
FIGURE 8 GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE, BY TYPE OF REGISTRY, 2020 (%) 39
FIGURE 9 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2020 & 2027 (USD MILLION) 39
FIGURE 10 GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE, BY FUNCTIONALITY, 2020 (%) 43
FIGURE 11 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2020 & 2027 (USD MILLION) 44
FIGURE 12 GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE, BY DEPLOYMENT MODEL, 2020 (%) 47
FIGURE 13 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2020 & 2027 (USD MILLION) 48
FIGURE 14 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, FOR ON-PREMISE, BY REGION, 2020–2027 (USD MILLION) 48
FIGURE 15 GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE, BY END USER, 2020 (%) 50
FIGURE 16 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 51
FIGURE 17 GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE, BY REGION, 2020 (%) 54
FIGURE 18 GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 54
FIGURE 19 AMERICAS: PATIENT REGISTRY SOFTWARE MARKET SHARE, BY REGION, 2020 (%) 55
FIGURE 20 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SHARE, BY COUNTRY, 2020 (%) 58
FIGURE 21 EUROPE: PATIENT REGISTRY SOFTWARE MARKET SHARE, BY REGION, 2020 (%) 66
FIGURE 22 WESTERN EUROPE: PATIENT REGISTRY SOFTWARE MARKET SHARE, BY COUNTRY, 2020 (%) 69
FIGURE 23 ASIA-PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SHARE, BY COUNTRY, 2020 (%) 84
FIGURE 24 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET SHARE, BY REGION, 2020 (%) 96
FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS 103
FIGURE 26 PATIENT REGISTRY SOFTWARE MARKET SHARE, COMPETITIVE LANDSCAPE, 2020 (%) 104
FIGURE 27 ARBORMETRIX: FINANCIAL OVERVIEW SNAPSHOT 109
FIGURE 28 ARBORMETRIX: SWOT ANALYSIS 111
FIGURE 29 DACIMA SOFTWARE INC.: SWOT ANALYSIS 114
FIGURE 30 EVADO PTY. LTD.: FINANCIAL OVERVIEW SNAPSHOT 115
FIGURE 31 EVADO PTY. LTD.: SWOT ANALYSIS 117
FIGURE 32 IFA SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT 119
FIGURE 33 IFA SYSTEMS: SWOT ANALYSIS 120
FIGURE 34 OPEN TEXT CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 122
FIGURE 35 OPEN TEXT CORPORATION: SWOT ANALYSIS 124
FIGURE 36 LUMEDX.: FINANCIAL OVERVIEW SNAPSHOT 125
FIGURE 37 LUMEDX.: SWOT ANALYSIS 126
FIGURE 38 MCKESSON CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT 129
FIGURE 39 MCKESSON CORPORATION.: SWOT ANALYSIS 130
FIGURE 40 OPTUM, INC.: FINANCIAL OVERVIEW SNAPSHOT 131
FIGURE 41 OPTUM, INC.: SWOT ANALYSIS 133
FIGURE 42 PHAMAX AG.: SWOT ANALYSIS 135
FIGURE 43 IBM: FINANCIAL OVERVIEW SNAPSHOT 136
FIGURE 44 IBM.: SWOT ANALYSIS 138
FIGURE 45 IQVIA: FINANCIAL OVERVIEW SNAPSHOT 140
FIGURE 46 IQVIA: SWOT ANALYSIS 141
